A careful history looking for the subtle symptoms of sinusitis ... Many patients with chronic sinusitis will have nasal exams that are not diagnostic and within normal limits.

Sinusitis is a condition that occurs when sinuses become inflamed due to infections Read this article to know what might be ...

It can be short-term or chronic. Sinusitis is quite common when the weather is cold and the symptoms can strike at any time causing discomfort. While over-the-counter medicines can be a great way ...

According to Dr Deepti Sinha, Lead Consultant, Dept of ENT at the CK Birla Hospital, understanding the causes, symptoms, and treatment options for winter sinusitis can help alleviate discomfort ...

(Photo Credit: Eric Olson/WebMD Ignite) The most common symptoms are a runny ... Nasal polyps make you more likely to have long-term (chronic) sinusitis. Large ones can even change the shape ...

"Chronic sinusitis affects as much as ... non-invasive treatment option for people who continue to experience symptoms after over-the-counter medications have failed." Millions of Americans ...

China approves GSK's Nucala for chronic rhinosinusitis with nasal polyps, adding to its existing uses in asthma and other ...

Researchers at the Washington University School of Medicine set out to determine whether the symptoms could ... diagnosis of acute sinusitis receiving initial antibiotic treatment.

Symptoms of sinusitis include a ... it may be chronic and can be diagnosed by an X-ray or CT scan at hospital. Appropriate treatment will then be given. Acute sinusitis will often settle on ...

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...

(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study.